Comparing shorter radiation after breast cancer surgery
Part of Cancer, Skin clinical trials.
This trial compares two different schedules of radiation therapy after breast cancer surgery to see if a shorter course is as effective. It may help reduce the number of hospital visits for patients who have had breast-conserving surgery or a mastectomy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have been diagnosed with invasive breast cancer.
- Your tumor was completely removed during surgery.
- You had breast-conserving surgery or a mastectomy.
- You had at least some lymph nodes removed from your armpit.
- Your cancer has not spread to distant parts of your body.
- You are willing to sign a consent form and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a shorter course of radiation (fewer, larger doses) with the standard longer course for women who have had breast cancer surgery with implant-based reconstruction. It aims to see if the shorter schedule is just as safe and effective for the chest area, while being more convenient.
This trial tests a shorter course of radiation therapy (called extreme hypofractionation) after surgery for early-stage breast cancer. It aims to see if fewer, higher-dose radiation sessions are as effective and safe as standard radiation, potentially reducing treatment time.
This study tests a shorter course of radiation therapy after breast reconstruction surgery for people with breast cancer. It aims to see if fewer, larger doses of radiation are safe and effective after mastectomy with reconstruction.
This trial compares two different schedules of radiation therapy after mastectomy and breast reconstruction. One uses standard daily doses over a longer period, and the other uses higher doses over a shorter period. The goal is to see if the shorter schedule works just as well while possibly saving time and reducing side effects.
This study compares a shorter course of radiation to a standard longer course after breast-conserving surgery (lumpectomy). It’s meant to see which schedule works just as well while focusing on safety and cancer control.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.